Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001397
Status:
COMPLETED
Last Update Posted:
2020-10-08
First Post:
1999-11-03
Brief Title:
Evaluation Treatment and Training for Patients With Blood Disorders
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Evaluation Treatment and Training Protocol for Patients With Bone Marrow Failure States Isolated or Multilineage Cytopenias Metastatic Solid Tumors or Hematologic Malignancies
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to allow the evaluation follow-up and medical care of patients with blood disorders not currently participating in a research study being conducted by the Hematology Branch of the National Heart Lung and Blood Institute NHLBI or not being screened for participation in a study
The purpose of this study is to allow investigation into the blood disorders of patients in order to teach learn and gather more information about diseases of the blood
In addition this study allows researchers the opportunity to evaluate patients referred to the Hematology Branch of the NHLBI with rare or undiagnosed diseases of the blood This may be potentially beneficial to the patient and at the same time contribute to the development of new research ideas
The purpose of this study is to allow investigation into the blood disorders of patients in order to teach learn and gather more information about diseases of the blood
In addition this study allows researchers the opportunity to evaluate patients referred to the Hematology Branch of the NHLBI with rare or undiagnosed diseases of the blood This may be potentially beneficial to the patient and at the same time contribute to the development of new research ideas
Detailed Description:
This protocol is designed to allow the evaluation follow up and standard medical care of patients and when appropriate their stem cell donor with bone marrow failure states cytopenias metastatic solid tumors or hematologic malignancies not currently entered on an active NHLBI protocol or not being screened for an active NHLBI research protocol Its purpose is to allow investigation into the hematologic problems of these patients for the primary purpose of teaching and furthering general hematologic knowledge The ability to evaluate and treat patients with a wide variety of hematologic disease is critical to maintaining our accreditation as a hematology fellowship program and training our fellows to be competent hematologists as well as for keeping all staff including senior staff up-to-date and familiar with the evaluation and treatment of patients with a wide spectrum of hematologic disease It also allows the NHLBI investigators to evaluate patients referred with rare or as yet undiagnosed hematologic problems both potentially benefiting the patient and stimulating new research directions for the NHLBI in the future Periodic follow-up and treatment of patients previously entered on NHLBI protocols in order to monitor the long-term course of the underlying hematologic state and the consequences of experimental treatments is also required for fellowship training and for maintenance of good referral relationships with patients and their physicians
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 94-H-0010 | None | None | None |